Tower Research Capital (TRC)’s Zosano Pharma Corporation ZSAN Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-829	Closed	-$36K	–	6177
2021 Q1	$36K	Buy	829 +200	+32%	+$8.38K	﹤0.01%	3411
2020 Q4	$12K	Buy	+629	New	+$12.3K	﹤0.01%	4236
2020 Q3	–	Sell	-317	Closed	-$9K	–	5254
2020 Q2	$9K	Buy	+317	New	+$8.95K	﹤0.01%	4082
2019 Q3	–	Sell	-41	Closed	-$5K	–	4704
2019 Q2	$5K	Buy	+41	New	+$4.85K	﹤0.01%	2983
2017 Q3	–	Hold	0	–	–	–	4269
2017 Q2	–	Hold	0	–	–	–	3699
2016 Q4	–	Sell	-1	Closed	-$1K	–	4602
2016 Q3	$1K	Sell	1 -1	-50%	-$797	﹤0.01%	3426
2016 Q2	$1K	Buy	2 +1	+100%	+$1.29K	﹤0.01%	4263
2016 Q1	$2K	Hold	1	–	–	﹤0.01%	3497
2015 Q4	$2K	Hold	1	–	–	﹤0.01%	3866
2015 Q3	$3K	Buy	+1	New	+$5.61K	﹤0.01%	3204
2015 Q2	–	Hold	0	–	–	–	4127
2015 Q1	–	Hold	0	–	–	–	3630

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Tower Research Capital (TRC)'s ZSAN Position: Q2 2021 in Review

Tower Research Capital (TRC) sold out of Zosano Pharma Corporation (ZSAN) in Q2 2021, closing a stake of 829 shares — an estimated $36K sold.

Tower Research Capital (TRC) first reported a position in ZSAN in Q3 2015 and held it in 9 quarters. The position peaked at $36K in Q1 2021. 34 funds tracked by Wall St. Rank hold ZSAN as of Q2 2021.

Tower Research Capital (TRC) reported no remaining Zosano Pharma Corporation position as of Q2 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 829 Zosano Pharma Corporation shares in Q2 2021, an estimated $36K.
Tower Research Capital (TRC) first reported a position in Zosano Pharma Corporation in Q3 2015 and held it in 9 quarters.
Tower Research Capital (TRC)'s Zosano Pharma Corporation position peaked at $36K in Q1 2021.
34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.